These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1507 related articles for article (PubMed ID: 31463827)

  • 21. Long non-coding RNA DLX6-AS1 facilitates bladder cancer progression through modulating miR-195-5p/VEGFA signaling pathway.
    Wang H; Niu X; Jiang H; Mao F; Zhong B; Jiang X; Fu G
    Aging (Albany NY); 2020 Aug; 12(16):16021-16034. PubMed ID: 32756011
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long non-coding RNA HAND2-AS1 inhibits gastric cancer progression by suppressing TCEAL7 expression via targeting miR-769-5p.
    Yu L; Luan W; Feng Z; Jia J; Wu Z; Wang M; Li F; Li Z
    Dig Liver Dis; 2021 Feb; 53(2):238-244. PubMed ID: 32952069
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long noncoding RNA NNT-AS1 promotes gastric cancer proliferation and invasion by regulating microRNA-363 expression.
    Wang X; Ren M; Li Y; Hu J; Lu G; Ma W; Guo D; Lu X; He S
    J Cell Biochem; 2019 Apr; 120(4):5704-5712. PubMed ID: 30324628
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long noncoding RNA DLX6-AS1 accelerates the glioma carcinogenesis by competing endogenous sponging miR-197-5p to relieve E2F1.
    Li X; Zhang H; Wu X
    Gene; 2019 Feb; 686():1-7. PubMed ID: 30366080
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Down-regulated lncRNA SLC25A5-AS1 facilitates cell growth and inhibits apoptosis via miR-19a-3p/PTEN/PI3K/AKT signalling pathway in gastric cancer.
    Li X; Yan X; Wang F; Yang Q; Luo X; Kong J; Ju S
    J Cell Mol Med; 2019 Apr; 23(4):2920-2932. PubMed ID: 30793479
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exosomal DLX6-AS1 from hepatocellular carcinoma cells induces M2 macrophage polarization to promote migration and invasion in hepatocellular carcinoma through microRNA-15a-5p/CXCL17 axis.
    Wang LP; Lin J; Ma XQ; Xu DY; Shi CF; Wang W; Jiang XJ
    J Exp Clin Cancer Res; 2021 May; 40(1):177. PubMed ID: 34039401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long noncoding RNA TMPO-AS1/miR-126-5p/BRCC3 axis accelerates gastric cancer progression and angiogenesis via activating PI3K/Akt/mTOR pathway.
    Hu Y; Zhang Y; Ding M; Xu R
    J Gastroenterol Hepatol; 2021 Jul; 36(7):1877-1888. PubMed ID: 33295056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Upregulated lncRNA DLX6-AS1 underpins hepatocellular carcinoma progression via the miR-513c/Cul4A/ANXA10 axis.
    Liu X; Peng D; Cao Y; Zhu Y; Yin J; Zhang G; Peng X; Meng Y
    Cancer Gene Ther; 2021 May; 28(5):486-501. PubMed ID: 33277615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HOXC-AS1-MYC regulatory loop contributes to the growth and metastasis in gastric cancer.
    Dong Y; Li X; Lin Z; Zou W; Liu Y; Qian H; Jia J
    J Exp Clin Cancer Res; 2019 Dec; 38(1):502. PubMed ID: 31870402
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long noncoding RNA ADPGK-AS1 promotes cell proliferation, migration, and EMT process through regulating miR-3196/OTX1 axis in breast cancer.
    Yang J; Wu W; Wu M; Ding J
    In Vitro Cell Dev Biol Anim; 2019 Aug; 55(7):522-532. PubMed ID: 31264061
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LncRNA TTN-AS1 promotes migration, invasion, and epithelial mesenchymal transition of lung adenocarcinoma via sponging miR-142-5p to regulate CDK5.
    Jia Y; Duan Y; Liu T; Wang X; Lv W; Wang M; Wang J; Liu L
    Cell Death Dis; 2019 Jul; 10(8):573. PubMed ID: 31363080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LINC01133 as ceRNA inhibits gastric cancer progression by sponging miR-106a-3p to regulate APC expression and the Wnt/β-catenin pathway.
    Yang XZ; Cheng TT; He QJ; Lei ZY; Chi J; Tang Z; Liao QX; Zhang H; Zeng LS; Cui SZ
    Mol Cancer; 2018 Aug; 17(1):126. PubMed ID: 30134915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long Noncoding RNA MNX1 antisense RNA 1 Exerts Oncogenic Functions in Bladder Cancer by Regulating miR-218-5p/RAB1A Axis.
    Wang J; Xing H; Nikzad AA; Liu B; Zhang Y; Li S; Zhang E; Jia Z
    J Pharmacol Exp Ther; 2020 Mar; 372(3):237-247. PubMed ID: 31843814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LncRNA SNHG6 is Associated with Poor Prognosis of Gastric Cancer and Promotes Cell Proliferation and EMT through Epigenetically Silencing p27 and Sponging miR-101-3p.
    Yan K; Tian J; Shi W; Xia H; Zhu Y
    Cell Physiol Biochem; 2017; 42(3):999-1012. PubMed ID: 28683446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The regulatory network of lncRNA DLX6-AS1/miR-149-5p/ERP44 is possibly related to the progression of preeclampsia.
    Liu R; Wang X; Yan Q
    Placenta; 2020 Apr; 93():34-42. PubMed ID: 32250737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long non-coding RNA DLX6-AS1 knockdown suppresses the tumorigenesis and progression of non-small cell lung cancer through microRNA-16-5p/BMI1 axis.
    Wu C; Lin W; Fu F
    Transl Cancer Res; 2021 Aug; 10(8):3772-3787. PubMed ID: 35116677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The lncRNA FEZF1-AS1 Promotes the Progression of Colorectal Cancer Through Regulating OTX1 and Targeting miR-30a-5p.
    Li J; Zhao LM; Zhang C; Li M; Gao B; Hu XH; Cao J; Wang GY
    Oncol Res; 2020 Feb; 28(1):51-63. PubMed ID: 31270006
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LncRNA PSMB8-AS1 contributes to pancreatic cancer progression via modulating miR-382-3p/STAT1/PD-L1 axis.
    Zhang H; Zhu C; He Z; Chen S; Li L; Sun C
    J Exp Clin Cancer Res; 2020 Sep; 39(1):179. PubMed ID: 32891166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Knockdown of TPT1-AS1 inhibits cell proliferation, cell cycle G1/S transition, and epithelial-mesenchymal transition in gastric cancer.
    Tang J; Huang F; Wang H; Cheng F; Pi Y; Zhao J; Li Z
    Bosn J Basic Med Sci; 2021 Feb; 21(1):39-46. PubMed ID: 32156253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
    Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
    Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 76.